-
DE
L10.0 Pemphigus Vulgaris – Causes, Symptoms, Treatment
L10.0 is the ICD-10 code for pemphigus vulgaris, a rare, severe autoimmune disease causing painful blisters on the skin and mucous membranes.
Add as Preferred SourceThings worth knowing about "L10.0"
L10.0 is the ICD-10 code for pemphigus vulgaris, a rare, severe autoimmune disease causing painful blisters on the skin and mucous membranes.
What is L10.0 – Pemphigus Vulgaris?
L10.0 is the ICD-10 diagnosis code for pemphigus vulgaris, the most common and most severe form within the pemphigus group of diseases. It is a rare, chronic autoimmune disorder in which the immune system mistakenly produces antibodies against proteins that hold skin and mucous membrane cells together. This leads to the formation of painful, fragile blisters (bullae) that rupture easily and leave behind raw, poorly healing wounds (erosions).
Causes
The exact cause is not fully understood, but several factors are known to play a role:
- Autoimmune reaction: Antibodies (primarily IgG) target the protein desmoglein 3 (and sometimes desmoglein 1), which is responsible for binding skin cells (keratinocytes) together.
- Genetic predisposition: Certain HLA genes (e.g., HLA-DR4, HLA-DQ1) are associated with increased disease risk.
- Triggering factors: Certain medications (e.g., penicillamine, ACE inhibitors), infections, or stress may trigger or worsen the disease.
Symptoms
The disease often begins in the mouth before spreading to other mucous membranes and the skin:
- Painful, soft blisters in the oral mucosa, frequently the first sign of the disease
- Skin blisters that break easily, leaving moist, open erosions
- Possible involvement of the throat, esophagus, genital mucosa, and conjunctiva
- Positive Nikolsky sign: Gentle lateral pressure on apparently healthy skin causes the outer layer to slip or separate
- Pain, burning, and difficulty eating or swallowing
Diagnosis
Diagnosis of pemphigus vulgaris requires a combination of clinical and laboratory investigations:
- Clinical examination: Assessment of blister morphology and the Nikolsky sign
- Skin biopsy: Histological demonstration of intraepithelial cleft formation (acantholysis) above the basal cell layer
- Direct immunofluorescence (DIF): Detection of IgG deposits between keratinocytes in a characteristic intercellular pattern
- Serology: Detection of circulating anti-desmoglein-3 antibodies in blood using ELISA
Treatment
Treatment aims to suppress the autoimmune response and promote wound healing:
Pharmacological Therapy
- Systemic corticosteroids: Prednisone or prednisolone are the primary first-line agents for rapid immune suppression
- Immunosuppressants: Azathioprine, mycophenolate mofetil, or cyclophosphamide are used as steroid-sparing agents
- Rituximab (anti-CD20 antibody): A biologic agent that depletes B cells; increasingly used as a first-line therapy in moderate to severe cases
- Intravenous immunoglobulins (IVIG): Used in severe, treatment-refractory cases
Supportive Measures
- Wound care and skin management to prevent secondary infections
- Pain management and oral or mucosal hygiene
- Nutritional support in cases of difficulty swallowing
- Osteoporosis prevention during long-term corticosteroid use
Prognosis
Pemphigus vulgaris is a chronic condition that can be life-threatening without treatment. However, with modern therapies – particularly rituximab – many patients can achieve prolonged remission or even complete remission. Regular dermatological follow-up remains essential.
References
- Murrell D.F. et al. – Diagnosis and Management of Pemphigus: Recommendations by an International Panel of Experts. Journal of the American Academy of Dermatology, 2020.
- Hertl M. et al. – European Guidelines for the Management of Pemphigus. Journal of the European Academy of Dermatology and Venereology (JEADV), 2015.
- World Health Organization – ICD-10 Version 2019, Code L10.0: Pemphigus vulgaris. Available at: https://icd.who.int/browse10/
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Skip product gallery
Subscription available
Floral
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®30 lozenges
Regular price:
22,90 €
Discount
Subscription available
Lactoferrin 60 Capsules
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
60 Capsules
Sale price:
50,00 €
Regular price:
59,90 €
Subscription available
Multivitamin Mineral Complex
Daily basic supply: the complete spectrum of micronutrients
Natural multivitamin complex for the immune system, energy, and central body functions
30 Capsules
Regular price:
29,90 €
Subscription available
Natural Iron
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
30 Capsules
Regular price:
35,90 €